Gomez Arteaga, Alexandra

Publications

Sort by

Co-Author Network

selected publications

Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial. Blood. 2026 Academic Article GET IT
Times cited: 4
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission. medRxiv : the preprint server for health sciences. 2025 Article GET IT
Beyond "favorable": early molecular response and outcomes in pediatric RUNX1::RUNX1T1 AML. Leukemia & lymphoma. 2025 Academic Article GET IT
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States. Transplantation and cellular therapy. 2025 Academic Article GET IT
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplantation and cellular therapy. 2025 Academic Article GET IT
Availability of Suitable Domestic Cord Blood Grafts for Adult Allograft Recipients With Hematologic Malignancies. Transplantation and cellular therapy. 2025 Academic Article GET IT
Times cited: 2
Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis. Haematologica. 2025 Information Resource GET IT
Times cited: 1
Precision medicine results from equitable representation. Bone marrow transplantation. 2024 Academic Article GET IT
Times cited: 2
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and cellular therapy. 2024 Academic Article GET IT
Times cited: 7
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors). Transplantation and cellular therapy. 2024 Academic Article GET IT
Times cited: 1
Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes. Leukemia & lymphoma. 2024 Information Resource GET IT
Times cited: 3
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nature communications. 2024 Academic Article GET IT
Times cited: 29
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and cellular therapy. 2023 Academic Article GET IT
Times cited: 6
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone marrow transplantation. 2023 Article GET IT
Times cited: 3
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone marrow transplantation. 2023 Article GET IT
Times cited: 1
Measurable residual disease after CAR T-cell therapy. Seminars in hematology. 2023 Information Resource GET IT
Times cited: 2
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
Times cited: 8
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 13
Reply to Caldwell et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Article GET IT
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 14
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances. 2022 Academic Article GET IT
Times cited: 14
Methods to monitor in vivo expansion and efficacy of CAR-T cells in preclinical models. Methods in cell biology. 2021 Academic Article GET IT
Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!. Leukemia & lymphoma. 2021 Article GET IT
Times cited: 1
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leukemia & lymphoma. 2021 Academic Article GET IT
Times cited: 4
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Academic Article GET IT
Times cited: 48
Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectations. Leukemia & lymphoma. 2021 Academic Article GET IT
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in oncology. 2021 Academic Article GET IT
Times cited: 18
Prognostic Factors for Postrelapse Survival after ex Vivo CD34⁺-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
Times cited: 2
Cord blood transplants supported by unrelated donor CD34⁺ progenitor cells. Bone marrow transplantation. 2020 Academic Article GET IT
Times cited: 6
Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series. Bone marrow transplantation. 2020 Article GET IT
Times cited: 4
Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Current opinion in hematology. 2020 Information Resource GET IT
Times cited: 12
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma. Bone marrow transplantation. 2019 Academic Article GET IT
Times cited: 22
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation. Leukemia & lymphoma. 2019 Article GET IT
Times cited: 32
Approaches to Targeting Cancer Stem Cells in Solid Tumors. Current stem cell research & therapy. 2019 Information Resource GET IT
Times cited: 5
Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Associated Lymphoma: A Single-Institution Experience. Clinical lymphoma, myeloma & leukemia. 2018 Academic Article GET IT
Times cited: 1
Minimal Residual Disease in Acute Myeloid Leukemia. Advances in experimental medicine and biology. 2018 Information Resource GET IT
Times cited: 16
Erratum: A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis. ACG case reports journal. 2017 Article GET IT
A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis. ACG case reports journal. 2016 Article GET IT
Times cited: 1
Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature. Clinical lymphoma, myeloma & leukemia. 2016 Article GET IT
Times cited: 9
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?. American journal of hematology. 2016 Academic Article GET IT
Times cited: 9
Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma. American journal of hematology. 2015 Academic Article GET IT
Times cited: 7
Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study. Breast cancer research and treatment. 2015 Academic Article GET IT
Times cited: 16
Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty. Cancer. 2013 Academic Article GET IT
Times cited: 19

more ...

less ...

Background

education and training

M.D., University of the Andes Faculty of Medicine (Colombia) 2011

Contact

full name

Alexandra Gomez Arteaga

primary email

alg9117@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Alexandra Gomez Arteaga Assistant Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage